Autres langues Tasly Pharmaceutical Group Co., Ltd

Actions

600535

CNE000001C81

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 18/09/2026			Varia. 5j.	Varia. 1 janv.
13,86 ^CNY	-0,57%		-1,14%	-8,03%

02/09	Tasly Pharmaceutical Group Co., Ltd : Opinion positive de CICC	ZM
24/08	Tasly Pharmaceutical va acquérir pour 4 milliards de yuans de produits de gestion de patrimoine	MT

Autres langues

24/08	Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products
24/08	Tasly Pharmaceutical's Subsidiary Secures Nod to Trial TSL2402 Tablets
11/08	Tasly Pharmaceutical Appoints Chair
20/07	Tasly Pharmaceutical Gets China Greenlight for Stroke Drug Trial
14/07	Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
16/06	Tasly Subsidiary Gets China Approval for Hypertension Drug
09/06	Tasly Gets China Approval for Traditional Insomnia Drops
29/05	Innovent Biologics Secures Up to $10.5 Billion Pfizer Oncology Deal
25/05	China Approves Tasly Pharmaceutical Subsidiary's Drug for Esophageal Irritation
27/04	Tasly Pharmaceutical's Profit Rises 18% in Q1; Shares Up 3%
24/04	Tasly pharmaceutical Q1 net profit up 17.8% Y/Y
24/04	Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
30/03	AP Biosciences and Tasly Pharmaceutical Group Co.Ltd. Finalize Amended Collaboration Agreement to Support Global Out-Licensing of AP505
20/03	Tasly Pharmaceutical's Profit Rises 16% in 2025
20/03	Tasly Pharmaceutical Signs Cooperation Deal for CAR-T Drug
19/03	Tasly Pharmaceutical Group Co., Ltd Proposes Cash Dividend
19/03	Tasly Pharmaceutical Group 2025 net profit up 15.6% Y/Y
09/02	Tasly Pharmaceutical Ends Deal to Grant Arbor Pharma Rights to Compound Danshen Dripping Pills
09/02	Tasly Pharmaceutical's Profit Rises 16% in 2025
06/02	Tasly Pharmaceutical Group 2025 prelim net profit up 15.7% Y/Y
06/02	Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
26/01	U.S. Food and Drug Administration Accepts Tasly 3P Characterization of Mscs Assay into Its Regulatory Framework
27/10/25	Tasly Pharmaceutical's Q3 Profit Rises 17%, Revenue Slips 3%; Shares Down 1%
24/10/25	Tasly pharmaceutical group Q3 net profit up 16.6% Y/Y
14/10/25	Tasly Pharmaceutical Gets Drug Registration Certificate for Wenjing Decoction Granules